Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of the study is to determine the efficacy of brain transplants of CD34+ stem cells obtained from peripheral blood of patients in the treatment of chronic stroke patients.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: China Medical University Hospital

Criteria

Inclusion Criteria:

• aged 35-70 chronic stroke adult patient,

• with stroke history of more than 6 months, less than 60 months，

• with stable hemiplegia condition, and

• NIHSS (NIH Stroke Scale) score is between 9-20.

Exclusion Criteria:

• patients aged less than 35 or more than 70,

• hemorrhage stroke or MRI show the occlusion is not in the middle cerebral artery territory，NIHSS is not in the range of 9-20,

• pregnant women,

• impaired liver function, abnormal blood coagulation, AIDS, combine other tumor or special condition.